Drug profile · INN
cycloserine
SEROMYCIN
cycloserine (SEROMYCIN) is a alanine racemase inhibitor. Associated with Sana Biotechnology. Route of administration: oral. Current US regulatory status: approved.
Drug details — cycloserine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 11
- Data quality
- 0.89
Quick answer
cycloserine (SEROMYCIN) is a alanine racemase inhibitor. Associated with Sana Biotechnology. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Alanine racemase inhibitor
Primary target: Alanine racemase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 12427199
Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments
granted -
US 12171822
Infectious plasmodium sporozoites grown in vitro
granted -
US 12129288
Polynucleotides heterodimers of soluble interferon receptors and uses thereof
granted -
US 12077543
P2X3 and/or P2X2/3 compounds and methods
granted -
US 11939343
Sting agonist compounds and methods of use
granted -
US 11883475
Infectious Plasmodium sporozoites grown in vitro
granted -
US 11434278
Protein-polymer-drug conjugates
granted -
US 11339169
P2X3 and/or P2X2/3 compounds and methods
granted -
US 11207395
Infectious plasmodium sporozoites grown in vitro
granted -
US 11155567
Sting agonist compounds and methods of use
granted -
US 10947295
Heterodimers of soluble interferon receptors and uses thereof
granted -
US 10772971
Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates
granted -
US 10660901
Pyrrolobenzodiazepines and conjugates thereof
granted -
US 10647720
Pyrimido-pyridazinone compounds and methods of use thereof
granted -
US 10611768
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10603386
Protein-polymer-drug conjugates
granted -
US 10590127
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10544145
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10537645
Protein-polymer-drug conjugates
granted -
US 10526294
Pyrrolobenzodiazepines and conjugates thereof
granted
Frequently asked questions
What is cycloserine?
cycloserine (SEROMYCIN) is a alanine racemase inhibitor. Associated with Sana Biotechnology. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cycloserine?
SEROMYCIN is a marketed brand name for cycloserine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cycloserine?
cycloserine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.